126 results
8-K
EX-99.1
BCDA
BioCardia Inc.
1 May 24
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
7:00am
of the CardiAMP clinical trials, ability to offset clinical costs utilizing Medicare reimbursement and the ultimate success of our clinical cell therapy programs
8-K
EX-99.1
BCDA
BioCardia Inc.
27 Mar 24
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
4:07pm
reimbursement to substantially offset the clinical costs of performing the study.
CardiAMP Autologous Cell Therapy for Chronic Myocardial Ischemia (BCDA-02 … of people suffering from heart disease, offset the costs of biotherapeutic delivery for our own programs, and provide our investors with meaningful
8-K
EX-99.1
1dtmuy80e1gplhk wuho
13 Mar 24
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
7:00am
8-K
EX-99.1
p5c4va5175x2sl5mqq
12 Mar 24
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
7:00am
8-K
EX-99.1
6td54 kbtg5
14 Nov 23
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure
12:00am
8-K
EX-99.1
nshsbdfni l338
8 Nov 23
Biocardia Reports Third Quarter 2023 Business Highlights and Financial Results
4:08pm